Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$275.25 - $318.06 $2.25 Million - $2.6 Million
8,185 New
8,185 $2.33 Million
Q3 2022

Nov 14, 2022

SELL
$194.69 - $268.46 $3.92 Million - $5.4 Million
-20,120 Reduced 50.9%
19,411 $5.18 Million
Q2 2022

Aug 12, 2022

SELL
$187.54 - $223.02 $3.19 Million - $3.79 Million
-17,000 Reduced 30.07%
39,531 $8.06 Million
Q1 2022

May 13, 2022

SELL
$193.77 - $244.14 $19.6 Million - $24.7 Million
-101,300 Reduced 64.18%
56,531 $11.9 Million
Q4 2021

Feb 14, 2022

BUY
$223.92 - $287.77 $4.78 Million - $6.15 Million
21,354 Added 15.65%
157,831 $37.9 Million
Q3 2021

Nov 12, 2021

BUY
$282.99 - $369.05 $14.7 Million - $19.1 Million
51,813 Added 61.2%
136,477 $38.6 Million
Q2 2021

Aug 13, 2021

BUY
$259.0 - $414.71 $14.6 Million - $23.3 Million
56,302 Added 198.51%
84,664 $29.3 Million
Q1 2021

May 14, 2021

BUY
$242.95 - $284.63 $1.94 Million - $2.27 Million
7,990 Added 39.22%
28,362 $7.93 Million
Q4 2020

Feb 12, 2021

BUY
$236.26 - $355.63 $359,115 - $540,557
1,520 Added 8.06%
20,372 $4.99 Million
Q3 2020

Nov 13, 2020

SELL
$264.77 - $305.71 $476,585 - $550,278
-1,800 Reduced 8.72%
18,852 $5.35 Million
Q2 2020

Aug 14, 2020

SELL
$258.66 - $342.55 $4.73 Million - $6.27 Million
-18,300 Reduced 46.98%
20,652 $5.53 Million
Q1 2020

May 14, 2020

BUY
$268.85 - $341.04 $618,355 - $784,392
2,300 Added 6.28%
38,952 $12.3 Million
Q4 2019

Feb 14, 2020

SELL
$220.06 - $304.07 $308,084 - $425,698
-1,400 Reduced 3.68%
36,652 $10.9 Million
Q3 2019

Nov 14, 2019

SELL
$217.44 - $243.88 $2.1 Million - $2.35 Million
-9,639 Reduced 20.21%
38,052 $8.86 Million
Q2 2019

Aug 09, 2019

SELL
$219.29 - $241.72 $5.73 Million - $6.32 Million
-26,142 Reduced 35.41%
47,691 $11.2 Million
Q1 2019

May 14, 2019

SELL
$216.71 - $338.96 $3.74 Million - $5.84 Million
-17,238 Reduced 18.93%
73,833 $17.5 Million
Q4 2018

Feb 14, 2019

BUY
$278.5 - $352.75 $3.4 Million - $4.31 Million
12,219 Added 15.5%
91,071 $27.4 Million
Q3 2018

Nov 14, 2018

BUY
$293.51 - $383.83 $21.2 Million - $27.8 Million
72,300 Added 1103.48%
78,852 $27.9 Million
Q2 2018

Aug 13, 2018

SELL
$257.52 - $306.91 $10.1 Million - $12 Million
-39,100 Reduced 85.65%
6,552 $1.9 Million
Q1 2018

May 14, 2018

BUY
$260.13 - $367.91 $3.06 Million - $4.33 Million
11,761 Added 34.7%
45,652 $12.5 Million
Q4 2017

Feb 13, 2018

SELL
$307.64 - $344.58 $4.14 Million - $4.64 Million
-13,461 Reduced 28.43%
33,891 $10.8 Million
Q3 2017

Nov 13, 2017

BUY
$281.15 - $329.69 $13.3 Million - $15.6 Million
47,352
47,352 $14.9 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Caisse De Depot Et Placement Du Quebec Portfolio

Follow Caisse De Depot Et Placement Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caisse De Depot Et Placement Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Caisse De Depot Et Placement Du Quebec with notifications on news.